Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Relations CareersResearchLicensingThe Merck Manuals

The Merck Manual of Geriatrics logo
red line
click here to go to the Contents page of The Merck Manual of Geriatrics
click here to go to the Title Page of The Merck Manual of Geriatrics
click here to search The Merck Manual of Geriatrics
you are at the Index of The Merck Manual of Geriatrics
red line
 
Index
Index A | Index B | Index C | Index D | Index E | Index F | Index G | Index H | Index I | Index J | Index K | Index L | Index M | Index N | Index O | Index P | Index Q | Index R | Index S | Index T | Index U | Index V | Index W | Index X,Y,Z

red line

Index N

Nabumetone 386t, 492t
Nadolol 843t
Nafcillin 1367t-1368t
in infective endocarditis 883t
Nails
age-related changes in 1235-1236
onycholysis of 1261
onychomycosis of 1261
physical examination of 32
Nalidixic acid 1372t
Naltrexone 339
Naproxen 386t
in osteoarthritis 492t
Narcotics (see Opioids)
Narrow QRS tachycardia 889-892
Nasogastric lavage 1107
Nasogastric tube 601, 602t
Nateglinide 631, 632t
Natural killer cells 1353
Nausea
in dying patient 118
opioid-induced 392
Neck
in carotid artery atherosclerosis 406t
in dizziness 188
pain in 1350
in physical examination 28t, 34
tumors of 1032, 1033
Necrosis 6
pressure, with intubation 791
Necrotizing external otitis 1335-1336
Nefedipine 977t
Neglect 149
Neomycin 1367t
Neoplasms (see Cancer and specific sites and types of neoplasms)
Nephrectomy 990
Nephrolithiasis, in hypercalcemia 576
Nephropathy (see also Kidneys, disease of)
diabetic 627, 628, 956, 957
membranous 956, 957
Nephrosclerosis 834-835
Nephrotic syndrome 954-957, 955t
Nephroureterectomy 995
Nerve(s)
biopsy of 519
conduction testing of, in muscular disorders 518, 518t
cutaneous 1234
Nerve cells
loss of 380-381
plasticity of 382-383
redundancy of 382
Nervous system (see also Brain; Peripheral nerves; Spinal cord)
age-related changes in 380-383, 381t, 382t
autonomic
      age-related changes in 756
disorders of (see Neurologic disorders)
examination of 28t, 36-38
     in falls 199
Netilmicin 1367t
Neuralgia
geniculate 1259
Morton's 553
postherpetic 1018, 1259-1260
     prevention of 1360t, 1367
     treatment of 1260-1261
tibial nerve 1350
trigeminal 1350
Neuroablation 396
Neurodermatitis 1251
Neurofibrillary tangles 381
Neurologic disorders (see also specific disorders)
amantadine-induced 1377t
depression and 311t
driving and 237
dysphagia in 1030-1031, 1031t
erectile dysfunction and 1167
in hypernatremia 567
in multiple myeloma 735
quinolone-induced 1372t
urinary incontinence with 968-969
in vitamin B12 deficiency 591, 592, 685
Neuroma
acoustic 184t, 1341-1342
amputation 286
Neuropathy
in alcoholism 336
autonomic 636
cranial 636
in diabetes mellitus 635, 636, 918
optic 1307
pudendal 1093
in vitamin B12 deficiency 591
Neurosyphilis 370
Neurotensin 382t
Neurotransmitter(s)
age-related changes in 381, 382t
of basal ganglia 429
Neutropenia, chemotherapy-induced 719
Nicardipine
in hypertension 843t
Nicotinic acid (niacin) 617, 618t-619t, 624
Nikolsky's sign 1257
Nipple, Paget's disease of 1218
Niridazole, sexual function and 1164t
Nisoldipine
in hypertension 843t
Nissen fundoplication 1120
in gastroesophageal reflux disease 1040
Nitrates (see also specific drugs)
in angina 856
after myocardial infarction 862t
sildenafil interaction with 1170
Nitrazepam, adverse effects of 65t
Nitrite test 983
Nitrofurantoin 1374t
sexual function and 1164t
Nitroglycerin
in achalasia 1035-1036
aging effect on 60t
in stable angina 856
in unstable angina 857
Nitroimidazoles 1371t
Nizatidine
alcohol interaction with 335
in peptic ulcer disease 1046
Nocturia 971, 972t, 976
Nocturnal myoclonus 459-460
Nodules, thyroid 653-654
Non-Hodgkin's lymphoma 747-752, 748t, 749t, 752t
Nonketotic hyperosmolar syndrome 638-639
Nonsteroidal anti-inflammatory drugs (NSAIDs)
adverse effects of 74, 491-492
alcohol interaction with 335
COX-2 inhibitors as (see COX-2 inhibitors)
diuretic interaction with 69t
in diverticular disease 1055t
in gout 495-496
hepatic metabolism of 58t
in osteoarthritis 491-492, 492t
in pain management 386t, 389-390
peptic ulcer disease and 1043
in polymyalgia rheumatica 509
in rheumatoid arthritis 501-502
in systemic lupus erythematosus 504
topical 493
Norepinephrine 60t, 1384t
Norethindrone 1216
Norfloxacin 1372t
in diarrhea 1091t
Normal-pressure hydrocephalus 371
Normocytic anemia 674t, 677-684
Nortriptyline 72, 394t
Norwalk virus infection 1086-1087
Nose
age-related changes in 1344
bleeding from 1345-1346
disorders of 1344-1347
dry 1345
foreign body in 1345
fracture of 1346-1347
mucous membrane disorders of 1345-1346
obstruction of 1344-1345
olfactory dysfunction of 1347
packing of 1346
in physical examination 32
polyps of 1344, 1345
NSAIDs (see Nonsteroidal anti-inflammatory drugs)
Nurse 77-79
in alcoholism treatment 339-340
in cancer treatment 722-723
clinical specialiest in gerontologic nursing 77
in elder abuse treatment 155
in fracture care 220
gerontologic nurse practitioner 77
geropsychiatric advanced practice nurse 77
in hospital 77, 97, 101-102
in incontinence 980
in interdisciplinary team 76t
in lung cancer treatment 805-806
in malnutrition treatment 602t, 603
in nursing home 107
in pain management 262-264
in Parkinson's disease management 441
postoperative functions of 262-264
preoperative functions of 242
in skin care 101-102
in stroke treatment 400
Nursing homes 105-110, 110t
abnormal suspiciousness in 330
AIDS care in 1382
behavior disorders in 371-372
dementia-related behavior disorders in 373t
hospital discharge to 104
hospital transfer from 104, 109
insomnia in 453
legal issues of 140-141
malnutrition management in 602t, 603
Medicare coverage for 105-106, 141, 165-166
patient abuse in 110
pharmacist in 85-86
placement in 106, 108
pneumonia in 758
quality of 109, 110t
quality of life and 114
selection of 109
sexual activity in 1157
tuberculosis testing in 766
utilization statistics for 17, 23t
Nutrition (see also Malnutrition)
in acute renal failure 961
age-related changes in 596-597
assessment of 598-601, 599f, 600t
in COPD 786
in dying patient 118
enteral 601-603, 602t
for frailty prevention 50t, 52
history of 26
during hospitalization 98-99
in malabsorption syndromes 1104
in malnutrition treatment 601-603, 602t
during mechanical ventilation 792
nursing strategies for 602t, 603
parenteral (see Parenteral nutrition)
physical examination of 38
postoperative 253-254
preoperative 244
in pressure sore treatment 1270-1271
in pulmonary rehabilitation 809
resources on 1416
tube feedings for 601-603, 602t
withholding of 139
Nystagmus 188, 189
Nystatin 1376t
in oral candidiasis 1018
Contact Merck Site MapAccessibility StatementPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.